The use of bioresorbable scaffolds (BRS) may be associated with benefits including restoration of endothelial function, positive vessel remodeling, and reduced risk for very late (stent) thrombosis compared with metallic stents by virtue of their complete absorption within 3 to 4 years of implantation. When treating bifurcation lesions, these advantages may be even more pronounced. The aim of this review is to summarize current experiences and technical considerations of bifurcation treatment with BRS. Because of the physical properties of current-generation BRS, there are concerns with regard to the efficacy and safety of this novel technology for the treatment of bifurcations, with the potential for increased rates of scaffold thrombosis and side-branch occlusions, and as a consequence, bifurcations have been excluded from the major BRS trials. Nevertheless, BRS have been used for this indication in clinical practice, as evidenced by "real-world" registries. Considering the potential limitations, specific technical considerations and modified bifurcation strategies should be used in an attempt to attenuate problems and achieve optimal procedural and clinical 
should be adopted with accepted techniques, including mini-crush, DK-crush, T-stenting, and culotte stenting (9) . However, these
techniques cannot be simply performed with BRS in a similar fashion to DES without taking into account the important differences in physical properties between the 2 platforms. As a consequence, when a BRS is being considered for the treatment of a bifurcation lesion, operators should consider the following: 1) fragility; 2) overexpansion limit; 3) strut thickness and width; and 4) deliverability and crossability. successful short-term results of planned 2-stent strategies (14, 22, 34) , even when implanting BRS, the provisional approach should be the default strategy for the majority of bifurcation lesions (Figure 1) .
However, because of the physical properties of current-generation BRS, there are some specific considerations (e.g., modified bifurcation techniques for crossover) that need to be taken into account with regard to the management of the SB: 1) SB occlusion; 2) strut disruption following SB ballooning or KBI; and 3) strut protrusion into the MB (Central Illustration). FOLLOWING BRS STENTING TO MB: THE POT. The POT is considered to be invaluable in ensuring adequate stent apposition in the proximal MB and to aid in SB rewiring (9) . Although it remains unclear whether the POT should be performed routinely in the context of bifurcation stenting, it is useful to facilitate SB rewiring due to the presence of bulky BRS struts straddling the ostium. As previously mentioned, the maximal overexpansion limit should be respected when performing the POT on the implanted BRS to prevent strut disruption. When treating a bifurcation lesion with a BRS, the provisional approach should be the default strategy for the majority of lesions. In circumstances where the SB is large and has a long lesion, treatment of the SB can be performed with a second BRS or with a metallic stent. BRS ¼ bioresorbable scaffold; D1 ¼ first diagonal branch; DES ¼ drug-eluting stent(s); EES ¼ everolimus-eluting stent(s); SB ¼ side branch. ELECTIVE DOUBLE-STENTING STRATEGY. The current evidence for the elective double-stenting strategy using BRS has been limited to case reports (23) (24) (25) 43, 46) and ex vivo bench tests (26) . In a small study (23 lesions) investigating clinical outcomes following elective double-stenting with BRS, the rate of target lesion revascularization at 1 year was 11% (22) . However, because of the small group of patients, patency rates of each specific 2-stent technique were not available.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S
In common with the technical aspects of provisional stenting, meticulous procedural techniques (Figure 7) (22,43) , a technique that can be broadly used for any bifurcation angle (47, 48) . This hybrid strategy is particularly useful for bifurcation lesions with narrow angles. In cases of an elective double-stenting strategy, the first KBI (after SB stenting) should be mandatory to reduce strut protrusion and jailing struts at the orifice of the SB (48, 49) .
SCAFFOLD OPTIMIZATION AND EFFECTIVE ANTI-THROMBOTIC THERAPY ARE ESSENTIAL.
With the use of metallic stents, adequate stent expansion and apposition confirmed by IVUS resulted in significant Meticulous procedural techniques that minimize strut protrusion into the main branch should be used to optimize results when an elective 2-scaffold/stent technique is used.
The specific technique should be determined on the basis of the bifurcation angle to minimize overlapping and protruding struts into the main branch at the site of the bifurcation lesion. To avoid overlapping BRS struts, a metallic DES can be considered for treatment of the side branch. KBI ¼ kissing balloon inflation; other abbreviations as in 
